Business Context and Reporting Period
This Form 8-K, dated May 30, 2017, reports on events occurring on May 26, 2017, for MRI Interventions, Inc. (Note: The request metadata lists "Clearpoint Neuro, Inc.", but the filing text explicitly identifies the registrant as MRI Interventions, Inc.). The report details the completion of a private placement financing transaction.
Key Financial Metrics
- Gross Proceeds: Approximately $13,250,000 raised from the sale of 6,625,000 units.
- Transaction Costs: Placement agent fees of $1,018,400 plus other offering expenses.
- Securities Issued: 6,625,000 shares of common stock and warrants to purchase 6,625,000 shares.
- Placement Agent Warrants: Approximately 509,200 warrants issued to placement agents.
- Pro Forma Equity: Stockholder equity increased from a deficit of approximately $2,200,000 to equity of approximately $9,600,000 as of March 31, 2017.
- Warrant Terms: Exercise price of $2.20 per share; exercisable until May 26, 2022.
Material Changes
The primary material change is the shift from a stockholder deficit to a positive equity position following the financing. The company moved from a deficit of approximately $2.2 million to approximately $9.6 million in equity on a pro forma basis as of March 31, 2017. This transaction significantly alters the company's capital structure and liquidity position.
Guidance, Outlook, and Risks
- Registration Rights: The company must file a registration statement with the SEC by June 25, 2017, to cover the resale of shares. Failure to file by this date, or to have it declared effective by August 9, 2017 (or September 3, 2017 if reviewed), will result in liquidated damages to investors.
- Warrant Features: Warrants include a "cashless exercise" feature and adjustments for fundamental transactions.
- Risks: The pro forma financial information is unaudited and does not necessarily reflect actual future results. Risks are referenced in the company's Form 10-K and Form 10-Q.
- Compliance: The sale was made to accredited investors under exemptions from registration (Section 4(a)(2) and Rule 506).
Investor Verification Checklist
- Verify the exact net proceeds after deducting all offering expenses beyond the stated placement agent fees.
- Confirm the filing status of the required Registration Statement by the June 25, 2017 deadline to avoid liquidated damages.
- Review the full text of the Securities Purchase Agreement and Warrants (Exhibits 10.1, 10.2, and 4.1) for specific covenants and adjustment mechanisms.
- Assess the company's cash runway and operational plans using the updated pro forma balance sheet (Exhibit 99.2).